Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magnitude Biosciences is a specialist contract research organization (CRO) that provides automated drug discovery and efficacy testing services using the nematode C. elegans. The company utilizes its proprietary WormGazer technology to monitor the effects of compounds on healthspan, longevity, and movement in a high-throughput, cost-effective manner. By bridging the gap between in vitro assays and mammalian in vivo studies, Magnitude Biosciences helps pharmaceutical, biotech, and nutraceutical companies accelerate their research in aging, neurodegeneration, and microbiome health. Their services include toxicity screening, lead optimization, and mechanism of action studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magnitude Group.